The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancer

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search UGSpace


Browse

My Account